In this study, we employed a mouse model of OSA to investigate whether selective pharmacological blockade of ET-1 type A (ETA) or type B (ETB) receptors would ameliorate IH-induced alterations in glucose metabolism such as whole-body glucose tolerance, insulin sensitivity and insulin secretion. The gene discussed is INS; the disease is obstructive sleep apnea syndrome.